{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T12:36:14Z","timestamp":1786538174035,"version":"build-2736575974"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T00:00:00Z","timestamp":1684368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211360\/Z\/18\/Z"],"award-info":[{"award-number":["211360\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Currently, diagnosis of latent TB infection (LTBI) is based on the secretion of IFN-\u03b3 in response to <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb) antigens, the absence of which is regarded as no infection. Some individuals appear to resist Mtb infection despite sustained exposure (resisters). In this study, we aimed to assess cytokines, chemokines and antibodies that may be associated with resistance to Mtb infection. We hypothesized that there may be an alternative immune response to Mtb exposure in the absence of IFN-\u03b3 in resisters.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled HIV-uninfected healthcare workers who had worked in high TB-exposure environments for 5 years or longer. We screened them for LTBI using the tuberculin skin test and the QuantiFERON-TB Gold Plus assay. We performed multiplex Luminex to measure concentrations of T cell-associated cytokines and chemokines as well as total antibodies in plasma collected from unstimulated fresh whole blood and supernatants from QuantiFERON-TB Gold Plus tubes following incubation of whole blood for 16-24 hours with ESAT6\/CFP10 peptides.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Samples from 78 individuals were analyzed: 33 resisters (TST&amp;lt;10mm; IGRA&amp;lt;0.35 IU\/mL), 33 with LTBI (TST\u226510mm and IGRA\u22650.35 IU\/mL) and 12 discordant (TST=0mm; IGRA\u22651.0 IU\/mL). There were no differences in concentrations of cytokines and chemokines in plasma between the different groups. Resisters had significantly lower concentrations of IFN-\u03b3, IL-2, TNF-\u03b1, MIP-1\u03b1, MIP-1\u03b2, ITAC, IL-13 and GM-CSF in supernatants compared with LTBI group. There were no significant differences in the concentrations in supernatants of IL-10, IL-1\u03b2, IL-17A, IL-21, IL-23, MIP-3\u03b1, IL-4, IL-5, IL-6, IL-7, IL-8, Fractalkine and IL-12p70 between the groups. We observed that resisters had similar concentrations of total antibodies (IgG1, IgG2, IgG3, IgG4, IgA, and IgM) in plasma and supernatants compared to the LTBI and discordant groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Resistance to Mtb infection despite sustained exposure is associated with lower Mtb-specific secretion of Th1-associated cytokines and chemokines. However, resisters showed secreted concentrations after Mtb stimulation of total antibodies and cytokines\/chemokines associated with innate and Th17 immune responses similar to those with Mtb infection. This suggests an ability to mount non-IFN-\u03b3 immune responses to Mtb in apparent resisters.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1176615","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:15:33Z","timestamp":1684397733000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Mycobacterial-specific secretion of cytokines and chemokines in healthcare workers with apparent resistance to infection with Mycobacterium tuberculosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Muki Shehu","family":"Shey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avuyonke","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nomawethu","family":"Masina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abulele","family":"Bekiswa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Schutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Goliath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Dielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick DMC.","family":"Katoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin Andrea","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lewinsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah Anne","family":"Lewinsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0025-3","article-title":"Immunological mechanisms of human resistance to persistent mycobacterium tuberculosis infection","volume":"18","author":"Simmons","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0441-3","article-title":"IFN-gamma-independent immune markers of mycobacterium tuberculosis exposure","volume":"25","author":"Lu","year":"2019","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619988","article-title":"Phenotype definition for \"Resisters\" to mycobacterium tuberculosis infection in the literature-a review and recommendations","volume":"12","author":"Gutierrez","year":"2021","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab269","article-title":"Resistance to mycobacterium tuberculosis infection among household contacts: a multinational study","volume":"73","author":"Baliashvili","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy751","article-title":"Long-term stability of resistance to latent mycobacterium tuberculosis infection in highly exposed tuberculosis household contacts in Kampala, Uganda","volume":"68","author":"Stein","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B6","first-page":"39","article-title":"Prevalence of latent tuberculosis infection among gold miners in south Africa","volume":"13","author":"Hanifa","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"key":"B7","unstructured":"Quantiferon-TB gold plus"},{"key":"B8","unstructured":"MILLIPLEX\u00ae human high sensitivity T cell magnetic bead panel"},{"key":"B9","unstructured":"Bio-plex pro\u2122 human isotyping panel, 6-plex #171A3100M"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106063242307","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"324","author":"Barnes","year":"1991","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s12879-020-05040-4","article-title":"Tuberculosis and its association with CD4(+) T cell count among adult HIV positive patients in Ethiopian settings: a systematic review and meta-analysis","volume":"20","author":"Geremew","year":"2020","journal-title":"BMC Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3298","article-title":"The burgeoning family of unconventional T cells","volume":"16","author":"Godfrey","year":"2015","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TBTB2-0018-2016","article-title":"Cytokines and chemokines in mycobacterium tuberculosis infection","volume":"4","author":"Domingo-Gonzalez","year":"2016","journal-title":"Microbiol Spectr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-019-10065-8","article-title":"Heterogeneous GM-CSF signaling in macrophages is associated with control of mycobacterium tuberculosis","volume":"10","author":"Bryson","year":"2019","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.4.1684-1693.2002","article-title":"Beta-chemokines are induced by mycobacterium tuberculosis and inhibit its growth","volume":"70","author":"Saukkonen","year":"2002","journal-title":"Infect Immun"},{"key":"B16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (IFN-gamma): exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol Concepts"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.8.1627.1627","article-title":"Interleukin-1 and interleukin-1 antagonism","volume":"77","author":"Dinarello","year":"1991","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(91)90142-G","article-title":"Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro","volume":"12","author":"Dinarello","year":"1991","journal-title":"Immunol Today"},{"key":"B19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.immuni.2012.01.018","article-title":"Inflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1","volume":"36","author":"Gross","year":"2012","journal-title":"Immunity"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.10.045","article-title":"Blocking IL-1alpha but not IL-1beta increases susceptibility to chronic mycobacterium tuberculosis infection in mice","volume":"29","author":"Guler","year":"2011","journal-title":"Vaccine"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.12.002","article-title":"Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during mycobacterium tuberculosis infection","volume":"35","author":"Mayer-Barber","year":"2011","journal-title":"Immunity"},{"key":"B22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/eji.200939583","article-title":"A role for IL-18 in protective immunity against mycobacterium tuberculosis","volume":"40","author":"Schneider","year":"2010","journal-title":"Eur J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1086\/427879","article-title":"Interleukin-12 receptor beta 1 chain deficiency in a child with disseminated tuberculosis","volume":"40","author":"Ozbek","year":"2005","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2013.58","article-title":"IL-17 cytokines in immunity and inflammation","volume":"2","author":"Jin","year":"2013","journal-title":"Emerg Microbes Infect"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1348-0421.2007.tb04008.x","article-title":"Interleukin-17 as an effector molecule of innate and acquired immunity against infections","volume":"51","author":"Matsuzaki","year":"2007","journal-title":"Microbiol Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141569","article-title":"IL-23-dependent IL-17 drives Th1-cell responses following mycobacterium bovis BCG vaccination","volume":"42","author":"Gopal","year":"2012","journal-title":"Eur J Immunol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.vaccine.2014.11.013","article-title":"BCG Vaccination-induced long-lasting control of mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4(+)IL-17(+)TNF(+)IL-2(+) T cells","volume":"33","author":"Cruz","year":"2015","journal-title":"Vaccine"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2014.01.004","article-title":"ESX1-dependent fractalkine mediates chemotaxis and mycobacterium tuberculosis infection in humans","volume":"94","author":"Hingley-Wilson","year":"2014","journal-title":"Tuberculosis (Edinb)."},{"key":"B29","doi-asserted-by":"publisher","first-page":"124762","DOI":"10.1155\/2015\/124762","article-title":"Binding of CXCL8\/IL-8 to mycobacterium tuberculosis modulates the innate immune response","volume":"2015","author":"Krupa","year":"2015","journal-title":"Mediators Inflamm"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2010.04168.x","article-title":"CCL20 is overexpressed in mycobacterium tuberculosis-infected monocytes and inhibits the production of reactive oxygen species (ROS)","volume":"162","author":"Rivero-Lezcano","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000321156","article-title":"Cysteine-cysteinyl chemokine receptor 6 mediates invariant natural killer T cell airway recruitment and innate stage resistance during mycobacterial infection","volume":"3","author":"Stolberg","year":"2011","journal-title":"J Innate Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.11.036","article-title":"CC chemokine receptor 4 contributes to innate NK and chronic stage T helper cell recall responses during mycobacterium bovis infection","volume":"178","author":"Stolberg","year":"2011","journal-title":"Am J Pathol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2011.7","article-title":"The role of IL-10 in immune regulation during m","volume":"4","author":"Redford","year":"2011","journal-title":"tuberculosis infect Mucosal Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.11.3815","article-title":"IL-10 inhibits cytokine production by activated macrophages","volume":"147","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.10.3444","article-title":"IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells","volume":"146","author":"Fiorentino","year":"1991","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.148.6.1792","article-title":"IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages","volume":"148","author":"Gazzinelli","year":"1992","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1613268","article-title":"Antibodies to mycobacterium tuberculosis","volume":"376","author":"Casadevall","year":"2017","journal-title":"N Engl J Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0028-0","article-title":"Antibodies and tuberculosis: finally coming of age","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A functional role for antibodies in tuberculosis","volume":"167","author":"Lu","year":"2016","journal-title":"Cell"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201606330","article-title":"Human isotype-dependent inhibitory antibody responses against mycobacterium tuberculosis","volume":"8","author":"Zimmermann","year":"2016","journal-title":"EMBO Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw141","article-title":"Association of human antibodies to arabinomannan with enhanced mycobacterial opsonophagocytosis and intracellular growth reduction","volume":"214","author":"Chen","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1176615\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:15:40Z","timestamp":1684397740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1176615\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2023.1176615"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1176615","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,18]]},"article-number":"1176615"}}